AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Ciprofloxacin USP in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Q-Bact tablets Tablet, Filmcoated | 249/004 | Saga Lifesciences Limited | active | 20 Nov 2029 |
Ciprofloxacin USP — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Ciprofloxacin USP, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Ciprofloxacin USP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.